文献速递头颈

世界卫生组织第五版头颈部肿瘤分类中的分子标志物

Molecular Markers in the World Health Organization Classification of Head and Neck Tumors, Fifth Edition.
PubMed 文献 · Radiographics · 2024-01-01

该文介绍世界卫生组织第五版头颈部肿瘤分类(HN5)基于分子标志物新增、删除和重新分类的肿瘤实体,并强调影像科医生作为多学科团队成员应了解这些变化,以更好理解肿瘤生物学并应用于临床实践。

要点

  • HN5分类基于分子标志物对头颈部肿瘤进行新增、删除和重新分类,使分类更客观和标准化。
  • 这些变化与治疗决策、预后和临床研究高度相关,对耐药疾病患者探索临床试验选项有重要意义。
  • HN5首次纳入放射科医生作为编写组成员,将相关影像学发现整合入分类。

核心结论

  • HN5基于分子标志物对头颈部肿瘤分类进行了重大修改,影像科医生应了解这些变化,以更好理解肿瘤生物学并整合入临床实践。

研究设计与样本

  • 综述,介绍世界卫生组织第五版头颈部肿瘤分类(HN5,2022年在线测试版)中上皮(包括鳞状细胞)和非上皮肿瘤的分子改变,并讨论新认识及重新分类的肿瘤实体和遗传性肿瘤综合征。

临床应用与阅片要点

  • 原文指出影像科医生作为多学科团队中不可或缺的一部分,应了解HN5基于分子标志物的分类变化,以更好理解肿瘤生物学并整合入临床实践。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The past decade has seen exponential advancements in molecular markers and the genetics of tumors, recognizing the limitations of conventional histopathology for grading, classification, and prognostication. Such advances have resulted in changes to classification systems, for example, with the incorporation of objective molecular and genetic information into the 2021 World Health Organization (WHO) classification of central nervous system tumors. The fifth edition of the WHO classification of head and neck tumors (HN5) (beta online version, 2022) also introduced major changes based on molecular markers, including additions, deletions, and reclassifications of entities, with the idea of being more objective and standardized. These changes are highly relevant to therapy decisions, prognosis, and clinical research and for patients with resistant diseases to explore options in clinical trials. The HN5, for the first time, included a radiologist as a member of the writing team to incorporate pertinent imaging findings into the classification. It is important for the radiologist, as an integral part of the multidisciplinary team, to be up to date about these changes for a better understanding of tumor biology, to integrate this into their clinical practice, and to provide more value in their interpretations. The authors provide a basic understanding of pathology and genetics for the radiologist, highlighting the molecular changes in epithelial (including squamous cell) and nonepithelial tumors of the head and neck. The authors also highlight newly recognized and reclassified tumor entities and provide a brief discussion on the genetic tumor syndromes. ©RSNA, 2024 Supplemental material is available for this article. See the invited commentary by Junn and Baugnon in this issue.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Agarwal A, Bathla G, Bhatt A, et al. Molecular Markers in the World Health Organization Classification of Head and Neck Tumors, Fifth Edition. Radiographics. 2024. PMID: 39356632. doi:10.1148/rg.240037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。